[go: up one dir, main page]

MX2008009579A - Metodo para el tratamiento de dolor neuropatico. - Google Patents

Metodo para el tratamiento de dolor neuropatico.

Info

Publication number
MX2008009579A
MX2008009579A MX2008009579A MX2008009579A MX2008009579A MX 2008009579 A MX2008009579 A MX 2008009579A MX 2008009579 A MX2008009579 A MX 2008009579A MX 2008009579 A MX2008009579 A MX 2008009579A MX 2008009579 A MX2008009579 A MX 2008009579A
Authority
MX
Mexico
Prior art keywords
neuropathic pain
treatment
compounds
slp
pain
Prior art date
Application number
MX2008009579A
Other languages
English (en)
Inventor
Kevin R Lynch
Timothy L Macdonald
Original Assignee
Univ Virginia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia filed Critical Univ Virginia
Publication of MX2008009579A publication Critical patent/MX2008009579A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporcionan compuestos y métodos útiles para prevenir y tratar dolor, por ejemplo, en un sujeto que necesita de los mismos. Los compuestos pueden ser agentes de "modulación SIP" que son capaces de inducir un cambio detectable en la actividad del receptor SIP.
MX2008009579A 2006-01-27 2007-01-29 Metodo para el tratamiento de dolor neuropatico. MX2008009579A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76258906P 2006-01-27 2006-01-27
PCT/US2007/002422 WO2007089715A2 (en) 2006-01-27 2007-01-29 Method for treatment of neuropathic pain

Publications (1)

Publication Number Publication Date
MX2008009579A true MX2008009579A (es) 2008-09-25

Family

ID=38179799

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008009579A MX2008009579A (es) 2006-01-27 2007-01-29 Metodo para el tratamiento de dolor neuropatico.

Country Status (13)

Country Link
US (1) US8008286B2 (es)
EP (1) EP1986623A2 (es)
JP (1) JP2009528274A (es)
KR (1) KR20080086546A (es)
CN (1) CN101378741A (es)
AU (1) AU2007209961A1 (es)
BR (1) BRPI0707281A2 (es)
CA (1) CA2640366A1 (es)
IL (1) IL193040A0 (es)
MX (1) MX2008009579A (es)
RU (1) RU2008134702A (es)
WO (1) WO2007089715A2 (es)
ZA (1) ZA200806349B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1827606A2 (en) 2004-12-06 2007-09-05 University Of Virginia Patent Foundation Aryl amide sphingosine 1-phosphate analogs
WO2007092638A1 (en) * 2006-02-09 2007-08-16 University Of Virginia Patent Foundation Bicyclic sphingosine 1-phosphate analogs
AU2007323540A1 (en) 2006-11-21 2008-05-29 University Of Virginia Patent Foundation Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
CA2669124A1 (en) * 2006-11-21 2008-05-29 University Of Virginia Patent Foundation Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
JP2010510249A (ja) 2006-11-21 2010-04-02 ユニバーシティ オブ バージニア パテント ファンデーション スフィンゴシン＝１−燐酸アゴニスト活性を有するテトラリンアナログ
WO2008079380A1 (en) 2006-12-21 2008-07-03 Abbott Laboratories Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane carboxylates
EP2177521A1 (en) 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
EP2210890A1 (en) 2009-01-19 2010-07-28 Almirall, S.A. Oxadiazole derivatives as S1P1 receptor agonists
EP2305660A1 (en) 2009-09-25 2011-04-06 Almirall, S.A. New thiadiazole derivatives
EP2343287A1 (en) 2009-12-10 2011-07-13 Almirall, S.A. New 2-aminothiadiazole derivatives
EP2366702A1 (en) 2010-03-18 2011-09-21 Almirall, S.A. New oxadiazole derivatives
EP2390252A1 (en) 2010-05-19 2011-11-30 Almirall, S.A. New pyrazole derivatives
US9682078B2 (en) * 2011-03-18 2017-06-20 University Of Virginia Patent Foundation Compositions and methods for tissue engineering and cell based therapies
TWI613182B (zh) 2013-02-21 2018-02-01 必治妥美雅史谷比公司 雙環化合物
AR101591A1 (es) 2014-08-20 2016-12-28 Bristol Myers Squibb Co Compuestos bicíclicos sustituidos
KR102805359B1 (ko) * 2019-11-14 2025-05-12 삼성전자주식회사 비트라인 전압을 제어하는 저항성 메모리 장치

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1056139B (de) 1956-03-31 1959-04-30 Hoechst Ag Verfahren zur Herstellung von alpha-Amino-beta-oxy-carbonsaeureaniliden
US3153092A (en) 1961-07-17 1964-10-13 Smith Kline French Lab 1-methyl-2-phenylcyclopropylamine derivatives
DE3544373A1 (de) 1985-12-14 1987-06-19 Hoechst Ag Verfahren zur herstellung von phosphinothricin-carboxamiden
ATE72816T1 (de) * 1986-11-21 1992-03-15 Ciba Geigy Ag Neue substituierte alkandiphosphonsaeuren.
US5646281A (en) * 1990-12-28 1997-07-08 Neurogen Corporation Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands
DE4134156A1 (de) * 1991-10-11 1993-04-15 Schering Ag 9-substituierte bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
JPH06135936A (ja) 1992-10-24 1994-05-17 Fuji Kagaku Kogyo Kk 新規なナフタレン誘導体及びその中間体
JPH06135935A (ja) 1992-10-24 1994-05-17 Fuji Kagaku Kogyo Kk 新規なナフタレン誘導体およびその中間体
AU1865499A (en) * 1997-12-30 1999-07-26 Allelix Biopharmaceuticals Inc. Identification of lysolipid receptors involved in inflammatory response
EP1258484B1 (en) 2000-02-18 2009-01-14 Kyowa Hakko Kirin Co., Ltd. Novel isoxazole and thiazole compounds and use thereof as drugs
US6875757B2 (en) * 2000-03-17 2005-04-05 University Of Tennessee Research Foundation LPA receptor agonists and antagonists and methods of use
EP1339390A2 (en) * 2000-12-06 2003-09-03 Pharmacia Corporation Laboratory scale milling process
DE60234092D1 (de) * 2001-01-30 2009-12-03 Univ Virginia Agonisten und antagonisten von sphingosin-1-phosphatrezeptoren
MXPA03008755A (es) 2001-03-26 2004-02-18 Novartis Ag Derivados de 2-amino-propanol.
JP2002316985A (ja) 2001-04-20 2002-10-31 Sankyo Co Ltd ベンゾチオフェン誘導体
ES2316613T3 (es) * 2001-05-10 2009-04-16 Ono Pharmaceutical Co., Ltd. Derivados de acido crboxilico y composiciones farmaceuticas que contienen los mismos como ingrediente activo.
BR0306811A (pt) 2002-01-11 2004-10-26 Sankyo Co Composto, éster farmacologicamente aceitável do mesmo, composição farmacêutica e métodos para prevenção ou tratamento de doenças autoimunes, da artrite reumatóide e da rejeição causada pelo transplante de vários órgãos em um mamìfero
AU2003216054B2 (en) 2002-01-18 2007-01-04 Merck & Co., Inc. Selective S1P1/Edg1 receptor agonists
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
US7241790B2 (en) * 2002-07-30 2007-07-10 University Of Virginia Patent Foundation Compounds active in spinigosine 1-phosphate signaling
US20060004040A1 (en) 2002-08-26 2006-01-05 Jilly Evans Method for the prevention and/or treatment of atherosclerosis
US7612238B2 (en) 2002-09-13 2009-11-03 Novartis Ag Amino-propanol derivatives
JP4509028B2 (ja) 2002-09-24 2010-07-21 ノバルティス アーゲー 有機化合物
US7045551B2 (en) 2002-11-22 2006-05-16 Bristol-Myers Squibb Company 1-aryl-2-hydroxyethyl amides as potassium channel openers
EP2172472B1 (en) 2003-02-18 2012-12-26 Kyorin Pharmaceutical Co., Ltd. Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor
WO2004089918A1 (ja) * 2003-04-09 2004-10-21 Japan Tobacco Inc. 複素芳香５員環化合物及びその医薬用途
JP2004307442A (ja) 2003-04-10 2004-11-04 Kyorin Pharmaceut Co Ltd ヘテロ環誘導体とその付加塩及び免疫抑制剤
ES2392167T3 (es) * 2003-04-30 2012-12-05 Novartis Ag Derivados aminopropanol como moduladores del receptor esfingosina-1-fosfato
WO2004096752A1 (en) 2003-04-30 2004-11-11 Novartis Ag Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
AU2004240586A1 (en) 2003-05-15 2004-12-02 Merck & Co., Inc. 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as S1P receptor agonists
MY150088A (en) 2003-05-19 2013-11-29 Irm Llc Immunosuppressant compounds and compositions
MXPA05012459A (es) * 2003-05-19 2006-02-22 Irm Llc Compuestos y composiciones inmunosupresoras.
EP1481680A1 (en) * 2003-05-30 2004-12-01 Aventis Pharma Deutschland GmbH Use of S1P
US20070043014A1 (en) 2003-10-01 2007-02-22 Merck & Co., Inc. 3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists
US7638637B2 (en) * 2003-11-03 2009-12-29 University Of Virginia Patent Foundation Orally available sphingosine 1-phosphate receptor agonists and antagonists
GB0411929D0 (en) 2004-05-27 2004-06-30 Novartis Ag Organic compounds
EP1760071A4 (en) 2004-06-23 2008-03-05 Ono Pharmaceutical Co COMPOUND WITH S1P RECEPTOR BINDING ABILITY AND USE THEREOF
WO2006020951A1 (en) 2004-08-13 2006-02-23 Praecis Pharmaceuticals, Inc. Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
US20060223866A1 (en) * 2004-08-13 2006-10-05 Praecis Pharmaceuticals, Inc. Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
EP1827606A2 (en) * 2004-12-06 2007-09-05 University Of Virginia Patent Foundation Aryl amide sphingosine 1-phosphate analogs
CA2596990A1 (en) * 2005-02-14 2006-08-24 University Of Virginia Patent Foundation Sphingosine 1-phosphate agonists comprising cycloalkanes and 5 -membered heterocycles substituted by amino and phenyl groups
DE602007003074D1 (de) 2006-01-24 2009-12-17 Actelion Pharmaceuticals Ltd Neue pyrinderivate
GB0601744D0 (en) 2006-01-27 2006-03-08 Novartis Ag Organic compounds
TW200806611A (en) 2006-02-09 2008-02-01 Daiichi Seiyaku Co Novel amidopropionic acid derivatives and medicine containing the same
WO2007092638A1 (en) * 2006-02-09 2007-08-16 University Of Virginia Patent Foundation Bicyclic sphingosine 1-phosphate analogs
CN101460458A (zh) * 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
EP1991535A1 (en) * 2006-02-21 2008-11-19 University Of Virginia Patent Foundation Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists
JP2010510249A (ja) 2006-11-21 2010-04-02 ユニバーシティ オブ バージニア パテント ファンデーション スフィンゴシン＝１−燐酸アゴニスト活性を有するテトラリンアナログ
AU2007323540A1 (en) 2006-11-21 2008-05-29 University Of Virginia Patent Foundation Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
CA2669124A1 (en) 2006-11-21 2008-05-29 University Of Virginia Patent Foundation Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
TW200838497A (en) * 2006-12-21 2008-10-01 Abbott Lab Sphingosine-1-phosphate receptor agonist and antagonist compounds
JP2010536791A (ja) 2007-08-15 2010-12-02 ユニバーシティ オブ バージニア パテント ファンデーション 二環式スフィンゴシン１−リン酸アナログ
CN101874015A (zh) 2007-09-28 2010-10-27 弗吉尼亚大学专利基金会 苄基-环烷基鞘氨醇1-磷酸酯受体调节剂
WO2009146112A1 (en) 2008-04-02 2009-12-03 University Of Virginia Patent Foundation Compositions and methods for inhibiting sphingosine kinase

Also Published As

Publication number Publication date
CA2640366A1 (en) 2007-08-09
KR20080086546A (ko) 2008-09-25
WO2007089715A2 (en) 2007-08-09
BRPI0707281A2 (pt) 2011-04-26
US8008286B2 (en) 2011-08-30
US20090062238A1 (en) 2009-03-05
AU2007209961A1 (en) 2007-08-09
WO2007089715A3 (en) 2007-09-27
CN101378741A (zh) 2009-03-04
RU2008134702A (ru) 2010-03-10
ZA200806349B (en) 2009-06-24
EP1986623A2 (en) 2008-11-05
JP2009528274A (ja) 2009-08-06
IL193040A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
MX2008009579A (es) Metodo para el tratamiento de dolor neuropatico.
TW200716624A (en) Compounds for modulating TRPV3 function
GB0701576D0 (en) Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same
WO2008079326A3 (en) Methods for using and identifying modulators of delta-like 4
MY147247A (en) Organic compounds and their uses
MX2009009292A (es) Compuestos activos en ppar.
SG170813A1 (en) New compounds
AP3091A (en) Agents for preventing and treating disorders involving modulation of the RYR receptors
NZ602571A (en) Micrornas that regulate muscle cell proliferation and differentiation
MX2009009290A (es) Compuestos activos en ppar.
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
MX2009006812A (es) Moduladores del receptor c3a y metodos de uso de los mismos.
WO2008011478A3 (en) Methods for treating chronic pain using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
WO2008011487A3 (en) L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
MX2009004134A (es) Tratamiento de trastornos de desmielinizacion con el receptor de linfotoxina beta soluble.
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
AU2016204334A1 (en) Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
TWI369590B (en) Treatment liquid for resist substrate, and method of treating resist substrate using the same
GB2473575A (en) Treatment and diagnosis of behavioural disorders
MX2007014638A (es) Dispositivo perforador de la piel para el tratamiento del acne.
MX2009009693A (es) Metodos para activar irs-1 y akt.
MX2010001187A (es) Moduladores del receptor ccr9 y metodos para su uso.
ZA200705840B (en) Method for treating fungoid growth of rhizoctonia, pythium and phytophthora
SI2155179T1 (sl) Aksomadol za zdravljenje bolečine pri artrozi

Legal Events

Date Code Title Description
FA Abandonment or withdrawal